AO Innovation Translation Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, AO Innovation Translation Center sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
AO Innovation Translation Center: 18 sponsored US clinical trials, 6 recruiting.
AO Innovation Translation Center sponsors 18 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Metastatic Spine Tumor, with 1 trials.
Top-decile sponsor footprint
AO Innovation Translation Center ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
18 total, page 1 of 1
Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems
NCT04921865
An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects
NCT04112992
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
NCT04098146
Fragility Fractures of the Pelvis (FFP)
NCT04182776
Periprosthetic Fracture Registry (PPFx)
NCT03378557
Primary Tumor Research and Outcomes Network
NCT02790983
Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children
NCT04207892
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
NCT04113044
Orbital Fractures Registry
NCT03887988
Metastatic Tumor Research and Outcomes Network
NCT02830451
A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders
NCT02802033
Prospective Multicenter Registry for Use of the MAXFRAME™ Multiaxial Correction System
NCT04017065
Focused Registry to Collect Clinical Data on the MatrixWAVE System
NCT03405389
Pediatric Femur Fracture Registry
NCT03211546
Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment
NCT02827214
Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program
NCT02297581
Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation
NCT01693367
Locking Plates for Distal Femur Fractures - a Multicenter Case Review
NCT04008940
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where AO Innovation Translation Center enrollment is open (later-stage tilt)
6 recruiting of 18 indexed (33% open); 5 completed (28%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Metastatic Spine Tumor (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AO Innovation Translation Center: open-pipeline peers nationwide
Peers matched on 18 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
AO Innovation Translation Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- Beckman Coulter · 18 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this AO Innovation Translation Center page
18 registered trials is a research-attention snapshot, not an endorsement of AO Innovation Translation Center or any single study.
- 6 of AO Innovation Translation Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Metastatic Spine Tumor is the condition AO Innovation Translation Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Metastatic Spine Tumor trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AO Innovation Translation Center pipeline card: 18 registered trials from official public datasets.Report a data error.